A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Clinical trial NCT04202003 · COMPLETED
Trial details
- NCT number
- NCT04202003
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-25
- Primary completion
- 2023-12-15
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.